Create Account | Sign In: Author or Forum

Search Symptoms

Category: Family Medicine | Gynecology | Pharmacy | Institutional

Back to Journal Articles

Pfizer Recalling 28 Lots of Oral Contraceptives

Last Updated: February 01, 2012.

Pfizer Inc. announced yesterday that it is voluntarily recalling specific lots of oral contraceptives upon learning of a packaging error that may put women at risk for unintended pregnancy, according to a safety alert issued by the U.S. Food and Drug Administration.

WEDNESDAY, Feb. 1 (HealthDay News) -- Pfizer Inc. announced yesterday that it is voluntarily recalling specific lots of oral contraceptives upon learning of a packaging error that may put women at risk for unintended pregnancy, according to a safety alert issued by the U.S. Food and Drug Administration.

The subjects of the recall are 14 lots each of Lo/Ovral-28 (norgestrel and ethinyl estradiol) Tablets and Norgestrel and Ethinyl Estradiol Tablets (generic). An investigation on behalf of the manufacturer found that some blister packets may contain tablets with an inexact count of active or inert ingredients, and that tablets may be out of sequence.

The packaging defects do not pose immediate health risks, but could leave women without adequate contraceptive protection. Women who may have been exposed to faulty packaging are advised to start using a non-hormonal form of birth control immediately, and to notify their physician and return packets to their pharmacy.

"These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy," Pfizer said in a statement.

More Information


Previous: ASCO: Radium-223 Promising for Prostate Cancer Bone Mets Next: AAP: Childhood Vaccination Schedules Approved for 2012

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: